ADVERTISEMENTREMOVE AD
Members Only
lock close icon

As Countries Halt AstraZeneca Vaccine, Should India be Concerned?

Countries including France Germany, Italy, Spain and Norway have halted the rollout of the inoculation program. 

Published
Podcast
1 min read
Aa
Aa
Small
Aa
Medium
Aa
Large
Hindi Female

The AstraZeneca- Oxford university COVID-19 vaccine has been paused by a number of countries in Europe after reports of blood clotting and Deep Vein Thrombosis in some participants arose. Countries including France Germany, Italy, Spain, Portugal and Norway have put a halt on the rollout of the inoculation programme for now and are examining the cases that have occurred.

While they carry out assessments, the World Health Organisation as well as the European Union’s vaccine regulator have played down the issue for now. They have highlighted two important points. One, there is no indication that the vaccine is linked to an increased risk of blood clots. Two, the number of cases in vaccinated people was no higher than in the general population.

In India, the Serum Institute of India is manufacturing the Oxford-AstraZeneca vaccine as Covishield and 1.5 crore doses have already been administered.

At a time when COVID-19 cases have seen a spike across India and Europe and the vaccination process is underway, a number of key questions have emerged. Why has this become an issue in the EU? Should India, which manufactures the same vaccine, be worried?

The Quint spoke with Dr Rahul Bhargava, Director and Head, Haematology and Bone Marrow Transplant at Fortis Memorial Research Institute, Gurugram

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

0

Read Latest News and Breaking News at The Quint, browse for more from podcast

Topics:  Podcast   astrazeneca   COVISHIELD 

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
×
×